{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:15:30Z","timestamp":1760300130747},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Taiho Pharmaceutical Co., Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/jjco\/hyy161","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T13:22:35Z","timestamp":1543324955000},"page":"121-129","source":"Crossref","is-referenced-by-count":7,"title":["A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy"],"prefix":"10.1093","volume":"49","author":[{"given":"Akihiko","family":"Osaki","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Breast Oncology, Saitama Cancer Center, Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Saitama Cancer Center, Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Minato","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyoshi","family":"Ohyanagi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo"},{"name":"Division of Pulmonary Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Kanagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokyo Medical University, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kagamu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Disease, Niigata University Medical and Dental Hospital, Niigata"},{"name":"Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Tamura","sequence":"additional","affiliation":[{"name":"Thoracic Center, St. Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"key\n\t\t\t\t2019020715394117500_hyy161C1","first-page":"5","article-title":"Best practice management of CINV in oncology patients: I. Physiology and treatment of CINV. Multiple neurotransmitters and receptors and the need for combination therapeutic approaches","volume":"8","author":"Frame","year":"2010","journal-title":"J Support Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C2","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","article-title":"Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment","volume":"24","author":"Bloechl-Daum","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00520-006-0173-z","article-title":"Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings","volume":"15","author":"Cohen","year":"2007","journal-title":"Support Care Cancer"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00520-004-0662-x","article-title":"Chemotherapy-induced nausea and vomiting in routine practice: a European perspective","volume":"12","author":"Glaus","year":"2004","journal-title":"Support Care Cancer"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/annonc\/mdv138","article-title":"Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review","volume":"26","author":"Jordan","year":"2015","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C6"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1200\/JCO.2015.64.3635","article-title":"Antiemetics: American Society of Clinical Oncology focused guideline update","volume":"34","author":"Hesketh","year":"2016","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C8","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-015-0852-1","article-title":"Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary","volume":"21","author":"Takeuchi","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2012.06.010","article-title":"In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist netupitant","volume":"37","author":"Rizzi","year":"2012","journal-title":"Peptides"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C11","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1200\/jco.2012.30.15_suppl.9054","article-title":"A positron emission tomography (PET) study to assess the degree of neurokinin-1 (NK1) receptor occupancy in the human brain after single doses of netupitant to healthy male subjects [abstract]","volume":"30","author":"Rossi","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jcph.198","article-title":"Netupitant PET imaging and ADME studies in humans","volume":"54","author":"Spinelli","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/annonc\/mdu110","article-title":"Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study","volume":"25","author":"Hesketh","year":"2014","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.08.049","article-title":"Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis","volume":"722","author":"Rojas","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1517\/14656566.2013.799141","article-title":"The current status of the use of palonosetron","volume":"14","author":"Navari","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/annonc\/mdu101","article-title":"A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy","volume":"25","author":"Aapro","year":"2014","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/2193-1801-3-389","article-title":"Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trial","volume":"3","author":"Spinelli","year":"2014","journal-title":"Springerplus"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","article-title":"Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial","volume":"10","author":"Saito","year":"2009","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","article-title":"Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan","volume":"20","author":"Tamura","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2015.09.005","article-title":"Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: rolapitant and NEPA (netupitant\/palonosetron)","volume":"41","author":"Rojas","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t2019020715394117500_hyy161C21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/14740338.2016.1135899","article-title":"The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting","volume":"15","author":"Navari","year":"2016","journal-title":"Expert Opin Drug Saf"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/49\/2\/121\/27724492\/hyy161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T02:51:11Z","timestamp":1605495071000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/49\/2\/121\/5253755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,12,20]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyy161","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,12,20]]}}}